Skip to content

Evaluating the Effectiveness of the Acute Respiratory Infection Smart Form

Evaluating Smart Forms and Quality Dashboards in an EHR: Effectiveness of the Acute Respiratory Infection Smart Form

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00235040
Enrollment
18257
Registered
2005-10-10
Start date
2005-11-30
Completion date
2007-08-31
Last updated
2012-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Tract Infections

Keywords

Upper Respiratory Infections, Respiratory Tract Infections, Tree Number C01.539.739, Tree Number C08.730, Unique ID D012141

Brief summary

To evaluate the effectiveness of the Acute Respiratory Infection Smart Form

Detailed description

Specific Aim 1: To design and implement an integrated documentation-based clinical decision support and physician feedback system, provided in an electronic health record (EHR), to improve the management of patients with acute medical conditions. Hypothesis 1: A documentation-based clinical decision support tool (CDSS) smart form physician feedback system, can be designed and implemented to facilitate documentation and physician order-entry, provide individualized, evidence-based recommendations for the management of patients acute respiratory infections (ARIs), and are usable by primary care physicians. Specific Aim 2: To determine the effectiveness of documentation-based CDSS and physician feedback on documentation and the clinical management of patients respiratory tract infections. Hypothesis 2A: A documentation-based CDSS smart form will increase the documentation of important clinical data in patients with ARI when compared to usual practice. Hypothesis 2B: A documentation-based CDSS smart form will increase adherence with guidelines for the management of patients with ARI when compared to usual practice.

Interventions

BEHAVIORALSmart Form

Computer Decision Support System

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Acute Respiratory Infection visit

Exclusion criteria

Any patients who are not part of a panel of a participating physician

Design outcomes

Primary

MeasureTime frame
Antibiotic prescribing rates9 months

Secondary

MeasureTime frame
Appropriateness of antibiotic prescribing, re-visit rates, antibiotic costs, use of antibiotics, all-cause antibiotic use, quality of documentation9 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026